Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Dermatology and Therapy|June 8, 2018
Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and AnalystsIsabelle M Sanchez, Lindsey Shankle, Marilyn T Wan, et al.
The Journal of Rheumatology. Supplement|June 3, 2020
The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 UpdatesYing Ying Leung, William Tillett, Ana-Maria Orbai, et al.
Seminars in Arthritis and Rheumatism|February 18, 2021
Measurement properties of radiographic outcome measures in Psoriatic Arthritis: A systematic review from the GRAPPA-OMERACT initiativeAnna Antony, Richard Holland, Maria-Antonietta D'Agostino, et al.
The Journal of Rheumatology|July 7, 2023
Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working GroupYing-Ying Leung, William Tillett, Maarten de Wit, et al.
The Journal of Rheumatology|May 3, 2016
Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual MeetingAna-Maria Orbai, Philip J Mease, Maarten de Wit, et al.
Rheumatology (Oxford, England)|March 22, 2021
What influences patients' opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international studyLaura C Coates, Danielle E Robinson, Ana-Maria Orbai, et al.
Joint Bone Spine|April 14, 2020
Determinants of sleep impairment in psoriatic arthritis: An observational study with 396 patients from 14 countriesPenélope Esther Palominos, Laura Coates, Charles Lubianca Kohem, et al.
The Journal of Rheumatology. Supplement|June 3, 2020
Proceedings of the 2019 GRAPPA Collaborative Research Network MeetingRobin Waxman, Carmel Stober, Deepak R Jadon, et al.
The Journal of Rheumatology|December 17, 2016
Stiffness Is the Cardinal Symptom of Inflammatory Musculoskeletal Diseases, Yet Still Variably Measured: Report from the OMERACT 2016 Stiffness Special Interest GroupSerena Halls, Premarani Sinnathurai, Sarah Hewlett, et al.
RMD Open|February 22, 2024
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITALLaura C Coates, Robert Landewé, Iain B McInnes, et al.
Pageof 11